A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies
Cancer - United States
doi 10.1002/cncr.31676
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Wiley